Kari Reinikainen - Concepedia

Author

Kari Reinikainen

University of Eastern Finland

Also Known As

KARI J. REINIKAINEN, Kari J. Reinikainen, Kari Juha Reinikainen, Kari Reinikainen

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of Eastern Finland Kuopio University Hospital Orion Corporation (Finland)Moisio Hospital University of Turku

About

Kari Reinikainen is an author at University of Eastern Finland specializing in medicine, alzheimer's disease, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	745
2	Social Sciences	7	7	349
3	Health Sciences	2	2	64
4	Anesthesia	1	1	13
5	Cognitive Science	1	1	46

Kari Reinikainen

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Subjective Memory Complaints and Personality Traits in Normal Elderly Subjects Tuomo Hänninen, Kari Reinikainen, Eeva‐Liisa Helkala, Journal of the American Geriatrics Society	1994	233
A Follow‐Up Study of Age‐Associated Memory Impairment: Neuropsychological Predictors of Dementia Tuomo Hänninen, Merja Hallikainen, Keijo Koivisto, Journal of the American Geriatrics Society	1995	187
Prevalence of Ageing-associated Cognitive Decline in an Elderly Population Tuomo Hänninen, Keijo Koivisto, Kari Reinikainen, Age and Ageing	1996	155
A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease Kari Reinikainen, Leo Paljärvi, Matti S. Huuskonen, Journal of the Neurological Sciences NeuropsychologyAlzheimer's DiseaseBrain FunctionNeurophysiologyMedicine	1988	153
Comparison of oxcarbazepine and carbamazepine: a double-blind study Kari Reinikainen, Tapani Keränen, Toivo Halonen, Epilepsy Research Psychoactive DrugAddictionDouble-blind StudyPharmacotherapyMedicine	1987	146
Dopaminergic system and monoamine oxidase-B Activity in Alzheimer's disease Kari Reinikainen, Leo Paljärvi, Toivo Halonen, Neurobiology of Aging Alzheimer's DiseaseDementiaNeuropharmacologyNeurochemical BiomarkersNeuroscience	1988	118
Entacapone improves the availability of <scp>l</scp>‐dopa in plasma by decreasing its peripheral metabolism independent of <scp>l</scp>‐dopa/carbidopa dose Helena Heikkinen, Anu Varhe, Tarmo Laine, British Journal of Clinical Pharmacology	2002	56
Lack of Adverse Interactions Between Concomitantly Administered Selegiline and Citalopram Kari Laine, Markku Anttila, Esa Heinonen, Clinical Neuropharmacology Drug SafetyDrug InteractionsHypertensionPsychiatrySelegiline Alone	1997	52
Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease Kari Alhainen, Juhani Partanen, Kari Reinikainen, Neuroscience Letters NeuropsychologyAlzheimer's DiseasePsychiatrySingle Dose Pharmaco-eegDementia	1991	52
Analysis and Quantitation of the β‐Amyloid Precursor Protein in the Cerebrospinal Fluid of Alzheimer's Disease Patients with a Monoclonal Antibody‐Based Immunoassay Thomas Henriksson, Robin Barbour, Sonia Braa, Journal of Neurochemistry	1991	48

Page 1